TEST:

ONCOCATCH-E

"EDGC (Eone Diagnomics Genome Center) said has successfully completed its acquisition of GDXLab, a CLIA (Clinical Laboratory Improvement Amendments) certified lab located in the southern part of Denver, Colorado...The acquisition of GDXLab is the latest achievement in EDGC’s efforts to expand into the North American market as the company recently received export permission for OncoCatch-E, a colon cancer diagnostic kit, from the Ministry of Food and Drug Safety..."

"Eone-Diagnomics Genome Center (EDGC) is on the verge of launching a blood-based multi-cancer early detection test that the firm hopes to ramp up in coming years to detect dozens of cancer types and potentially non-cancer applications such as Alzheimer's progression...The South Korea-based joint venture between bioinformatics firm Diagnomics and clinical laboratory firm Eone Laboratories says it plans to launch its OncoCatch-E epigenetic liquid biopsy assay by early 2024 as a laboratory-developed test that would compete in the emerging MCED market."